Dóchas Life Sciences’ Post

Implications of new clinical practice guidance on familial hypercholesterolaemia for Australian general practitioners - RACGP: Implications of new clinical practice guidance on familial hypercholesterolaemia for Australian general practitioners  RACGP

Implications of new clinical practice guidance on familial hypercholesterolaemia for Australian general practitioners - RACGP: Implications of new clinical practice guidance on familial hypercholesterolaemia for Australian general practitioners  RACGP

A timely view! Our patients are becoming increasingly more conplex and co-morbid- a make believe clinical trial participant cannot answer difficult questions pertaining to such ambiguities. Not only that, pharmaceutical sponsored trials while shape evidence, can also make the waters mirky. Give me evidence based medicine for a real life patient anytime! #ebm #clinical trials # clinical practice

In 2012, the World Health Assembly established the Member State Mechanism (MSM), to address the issue of tackling Substandard and Falsified Medical Products (SMFP) in a transparent and inclusive way, from a public health perspective and expressly excluding considerations of intellectual property rights. On 29 May 2017, the World Health Assembly agreed to have “Substandard and Falsified (SF) medical products” as the term to be used in the name of the Member State mechanism and in all future documentation on the subject of medical products of this type. For more information, please see Resolution 65.19. The Annex to WHA65.19 contains the goal, objectives, and terms of reference. The above reference is very key to the interpretations that may follow any actions or activities related therein.

A new JAMA Special Communication explains how clinical trials are falling short compared to the decisions faced every day in clinical practice. Listen to a conversation about the article with JAMA Senior Editor Derek Angus and JAMA Editor in Chief Kirsten Bibbins-Domingo: https://ja.ma/45exBwj Read the accompanying Special Communication: https://ja.ma/4aJ0li5

Come connect with fellow kidney practitioners and hear from expert thought leaders on a broad array of trending practice management and clinical topics. Registration here: https://lnkd.in/eAStDvCy #RPA #KidneyPractitioners #PracticeManagement

The new video is online on our YouTube channel: "MS 39 in clinical practice: challenging cases" Riccardo Vinciguerra, MD https://lnkd.in/ecVP9Qd5 #csoitalia #riccardovinciguerra #ms39 #clinicalpractice #OphthalmicInstruments #Ophthalmology Riccardo Vinciguerra

A paper with important clinical implications: continuity of care results in much better engagement with treatment following an emergency presentation with self-harm rdcu.be/dya3u

Interesting news about the status of clinical guidelines in Kazakhstan Starting June 20, clinical guidelines in Kazakhstan will officially become voluntary. An amendment to the Health Code states: "Medical workers are guided by clinical guidelines when choosing the most effective methods of prevention, diagnosis, treatment, and rehabilitation, which are voluntary". The global trend is towards personalized medicine, as treating every patient with the same template is not ideal. I hope these new amendments will help improve care for every patient. Link to the law in the comment below.

This week, Dr, Powles discusses quality of life measurement in clinical trials and how they, while imprecise, can augment the clinical data to inform practice...